News|Articles|May 2, 2005

Pharmaceutical Technology

  • Pharmaceutical Technology-05-02-2005
  • Volume 29
  • Issue 5

Price Matters

Author(s)Jim Miller

Major pharmaceutical companies are focusing more than ever on the prices CROs are charging for their services.


Related to this article

FDA
FDA opens applications for its Expedited IND Pilot, pairing sponsors with qualified research institutions to test rolling CMC review ahead of first-in-human trials.